17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model
Sandeep S. Joshi(University of Maryland, Baltimore), Thomas J. Hornyak(VA Maryland Health Care System)
Cited by 15
Related Papers
EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/ <i>CDKN1A</i> Expression
|Molecular Cancer Research|2011|191